Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 8/20 | 0.66 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.53 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.52 |
| ▸ | KDM1A | O60341 | 1/20 | 0.51 |
| ▸ | MAOA | P21397 | 1/20 | 0.51 |
| ▸ | MAOB | P27338 | 1/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | RAB9A | P51151 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL8092779 | 0.98 | SIGMAR1 (0.64) | SIGMAR1KCNH2EPHX2KDM1AMAOA | |
| SCHEMBL8569329 | 0.88 | SIGMAR1 (0.67) | SIGMAR1EPHX2EPHX1 | |
| SCHEMBL7419921 | 0.86 | SLC18A3 (0.60) | SIGMAR1EPHX2KDM1AMAOAMAOB | |
| SCHEMBL9133642 | 0.86 | SLC18A3 (0.60) | SIGMAR1EPHX2KDM1AMAOAMAOB | |
| SCHEMBL2440428 | 0.86 | SLC18A3 (0.60) | SIGMAR1EPHX2KDM1AMAOAMAOB | |
| SCHEMBL8084177 | 0.85 | SIGMAR1 (0.58) | SIGMAR1KCNH2EPHX2KMT2AEPHX1 | |
| SCHEMBL31547204 | 0.85 | SIGMAR1 (0.88) | SIGMAR1KDM1AMAOAMAOBKMT2A | |
| SCHEMBL6049169 | 0.84 | SIGMAR1 (0.61) | SIGMAR1EPHX2KMT2AEPHX1MEN1 | |
| SCHEMBL7103234 | 0.84 | SLC18A3 (0.62) | SIGMAR1 | |
| SCHEMBL5087578 | 0.83 | SIGMAR1 (0.64) | SIGMAR1EPHX2KMT2AEPHX1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6057371-A | TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS, GASTROINTESTINAL DISORDERS, DRUG ABUSE, ANGINA, MIGRAINE, HYPERTENSION AND DEPRESSION | VIRGINIA COMMONWEALTH UNIVERSITY (US) | 2000-05-02 | — | — | US | claimed |
| EP-0591426-A1 | SIGMA RECEPTOR LIGANDS AND THE USE THEREOF | VIRGINIA COMMONWEALTH UNIVERSITY (US) | 1994-04-13 | — | — | EP | claimed |
| WO-1993000313-A2 | SIGMA RECEPTOR LIGANDS AND THE USE THEREOF | VIRGINIA COMMONWEALTH UNIVERSITY (US) | 1993-01-07 | — | — | WO | claimed |
| WO-1991009594-A1 | SIGMA RECEPTOR LIGANDS AND THE USE THEREOF | VIRGINIA COMMONWEALTH UNIVERSITY (US) | 1991-07-11 | — | — | WO | claimed |